Who We Are
Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.
Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.
Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.
Key Issues
Causes We Care About, and So Should You!
HIV
Promote necessary funding, programs, and policies to end the HIV epidemic in the United States
HEPATITIS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
HEALTHCARE ACCESS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
Facebook posts by @HIV+Hep
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment (Gift Article)
New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.Advocates’ Frustration Mounts Amid CMS Inaction on Copay Accumulators
Language stating CMS will enforce a court ruling regarding the use of copay accumulator programs is missing from a new regulation.